Bloomberg Opinion columnist Barry Ritholtz interviews Todd Harrison, a founding partner and chief investment officer at the hedge fund CB1 Capital, which focuses on cannabinoid-based solutions and biopharmaceutical applications and therapies. Prior to his work with CB1 Capital, Harrison spent almost three decades on Wall Street managing risk and researching financial market strategies. He was also the

founder and CEO of Minyanville Media Inc., an Emmy-winning financial media company covering global markets in real time. 

Bloomberg Opinion columnist Barry Ritholtz interviews Todd Harrison, a founding partner and chief investment officer at the hedge fund CB1 Capital, which focuses on cannabinoid-based solutions and biopharmaceutical applications and therapies. Prior to his work with CB1 Capital, Harrison spent almost three decades on Wall Street managing risk and researching financial market strategies. He was also thefounder and CEO of Minyanville Media Inc., an Emmy-winning financial media company covering global markets in real time.

Bloomberg Radio host Barry Ritholtz has in-depth discussions with the people and ideas that shape markets, investing and business.

Bloomberg Radio host Barry Ritholtz has in-depth discussions with the people and ideas that shape markets, investing and business.

Bloomberg's Barry Ritholtz looks at the people and ideas that shape markets, investing and business.

Masters in Business

Todd Harrison Discusses Biopharmaceutical Investments

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/445c2ad4-8745-422d-a05e-ae2b0030e02e/transcript

Advertisement